1. Home
  2. BNR vs CPSH Comparison

BNR vs CPSH Comparison

Compare BNR & CPSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$9.31

Market Cap

94.4M

Sector

Health Care

ML Signal

N/A

Logo CPS Technologies Corp.

CPSH

CPS Technologies Corp.

N/A

Current Price

$4.21

Market Cap

90.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
BNR
CPSH
Founded
2014
1984
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Building Materials
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
94.4M
90.8M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
BNR
CPSH
Price
$9.31
$4.21
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
4.2K
277.6K
Earning Date
06-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
113.64
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$111.65
$16.41
Revenue Next Year
N/A
$20.16
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.79
$2.87
52 Week High
$41.72
$14.39

Technical Indicators

Market Signals
Indicator
BNR
CPSH
Relative Strength Index (RSI) 53.93 43.55
Support Level $8.69 $3.10
Resistance Level $10.00 $4.90
Average True Range (ATR) 0.52 0.27
MACD 0.07 0.07
Stochastic Oscillator 50.58 53.85

Price Performance

Historical Comparison
BNR
CPSH

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About CPSH CPS Technologies Corp.

CPS Technologies Corp designs, manufactures, and sells high-performance material solutions for customers across various markets, including transportation, energy, automotive, electronics, telecommunications, aerospace, and defense. The company develops and applies proprietary expertise in metal matrix composites (MMCs), which are engineered materials combining metals and ceramics to achieve enhanced performance properties. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers. The majority of the company's revenue is derived from the sale of its products in the United States of America.

Share on Social Networks: